rss
BMJ Case Reports 2016; doi:10.1136/bcr-2016-215444
  • CASE REPORT

Laryngeal leishmaniasis in a patient taking inhaled corticosteroids

  1. David Phillips3
  1. 1Department of Intensive Care Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, UK
  2. 2Department of Respiratory Medicine, Warwick Hospital, Warwick, UK
  3. 3Warwick Hospital, Warwick, UK
  1. Correspondence to Dr Rachel Margaret Roberts, rachel.cary{at}gmail.com
  • Accepted 7 June 2016
  • Published 21 June 2016

Summary

We present a case of a man in his late 60s, who had spent 3–4 months of the year in rural Spain, presenting with intermittent hoarseness of voice. He had a background of asthma and bronchiectasis, and was taking inhaled corticosteroids. His dysphonia was initially managed as bronchiectasis with little improvement. Bronchoscopy revealed a cystic lesion on his left vocal fold, and tissue biopsy revealed Leishmania amastigotes. This confirmed a diagnosis of laryngeal leishmaniasis. We propose that this is likely secondary to his inhaled corticosteroid therapy. The infection was treated with a 30-day course of miltefosine, and at most recent follow-up the patient was deemed free from leishmanial infection.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article